These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
319 related items for PubMed ID: 8003818
1. Heterogeneous immunoreactivity of frozen human benign and malignant breast lesions to C-MYC and C-Ha-ras cellular oncogenes. Pechoux C, Chardonnet Y, Chignol MC, Noël P. Histol Histopathol; 1994 Jan; 9(1):35-44. PubMed ID: 8003818 [Abstract] [Full Text] [Related]
2. [Human papillomaviruses and cellular oncogenes (c-myc, c-Ha-ras) in cutaneous and mucosal lesions in transplantation recipients]. Pélisson I, Soler C, Chignol MC, Euvrard S, Chardonnet Y. Bull Cancer; 1992 Jan; 79(5):471-82. PubMed ID: 1330099 [Abstract] [Full Text] [Related]
3. Immunohistochemical study of oncogene product ras p21, c-myc and growth factor EGF in breast carcinomas. Mizukami Y, Nonomura A, Noguchi M, Taniya T, Koyasaki N, Saito Y, Hashimoto T, Matsubara F, Yanaihara N. Anticancer Res; 1991 Jan; 11(4):1485-94. PubMed ID: 1660689 [Abstract] [Full Text] [Related]
4. Expression of c-myc, erbB-2, p53 and nm23-H1 gene product in benign and malignant breast lesions: coexpression and correlation with clinicopathologic parameters. Sirotkovic-Skerlev M, Krizanac S, Kapitanovic S, Husnjak K, Unusic J, Pavelic K. Exp Mol Pathol; 2005 Aug; 79(1):42-50. PubMed ID: 16005711 [Abstract] [Full Text] [Related]
5. Genetic alterations of c-myc, c-erbB-2, and c-Ha-ras protooncogenes and clinical associations in human breast carcinomas. Garcia I, Dietrich PY, Aapro M, Vauthier G, Vadas L, Engel E. Cancer Res; 1989 Dec 01; 49(23):6675-9. PubMed ID: 2573420 [Abstract] [Full Text] [Related]
6. Enhanced expression of c-Ha-ras p21 in human stomach adenocarcinomas defined by immunoassays using monoclonal antibodies and in situ hybridization. Ohuchi N, Hand PH, Merlo G, Fujita J, Mariani-Costantini R, Thor A, Nose M, Callahan R, Schlom J. Cancer Res; 1987 Mar 01; 47(5):1413-20. PubMed ID: 2434216 [Abstract] [Full Text] [Related]
14. An immunohistochemical and in situ hybridization study of c-myc and c-erbB-2 expression in primary human breast carcinomas. Walker RA, Senior PV, Jones JL, Critchley DR, Varley JM. J Pathol; 1989 Jun 01; 158(2):97-105. PubMed ID: 2569035 [Abstract] [Full Text] [Related]
15. Expression of ras and c-myc oncoproteins and hepatitis B surface antigen in human liver disease. Tiniakos D, Spandidos DA, Yiagnisis M, Tiniakos G. Hepatogastroenterology; 1993 Feb 01; 40(1):37-40. PubMed ID: 8462926 [Abstract] [Full Text] [Related]
17. Phosphotyrosine, p62 c-myc and p21 c-Ha-ras proteins in colonic epithelium of normal and dimethylhydrazine-treated rats: an immunohistochemical analysis. Schwartz B, Benharroch D, Prinsloo I, Cagnano E, Lamprecht SA. Anticancer Res; 1995 Feb 01; 15(1):211-8. PubMed ID: 7537485 [Abstract] [Full Text] [Related]
18. Ontogeny of Ha-ras and c-myc mRNA levels in rabbit embryo and extraembryonic tissues by quantitative in situ hybridization. Martinoli MG, Lambert RD, Pothier F, Pelletier G. Mol Reprod Dev; 1992 Jan 01; 31(1):1-8. PubMed ID: 1562321 [Abstract] [Full Text] [Related]
19. A possible role for human papillomaviruses and c-myc, c-Ha-ras, and p53 gene alterations in malignant cutaneous lesions from renal transplant recipients. Pelisson I, Soler C, Chardonnet Y, Euvrard S, Schmitt D. Cancer Detect Prev; 1996 Jan 01; 20(1):20-30. PubMed ID: 8907200 [Abstract] [Full Text] [Related]
20. Immunohistochemistry, in situ hybridization and polymerase chain reaction (PCR) in detecting c-myc expression in human malignancies. Tervahauta AI, Syrjänen SM, Kallio PJ, Syrjänen KJ. Anticancer Res; 1992 Jan 01; 12(3):1005-11. PubMed ID: 1622111 [Abstract] [Full Text] [Related] Page: [Next] [New Search]